ED Medical / Imune Support (colloidal phyto-formula for harmonizing immunity from ED Medical (USA))

Description

Manufacturer: ED Medical; Release form: liquid; Contraindications: individual intolerance, periods of pregnancy and lactation, insomnia, increased nervous irritability, severe atherosclerosis; Age restrictions: 12+; Category: for immunity, for general strengthening of the body; Packing: glass bottle; Product weight with packaging (g): 800 g; Product weight without packaging (g): 600 g; Minimum storage temperature: -40 ° С; Maximum storage temperature: +25 ° C; Expiration date: 36 months; Package contents: instruction, bottle Colloidal solution of increased bioavailability in the form of a stabilized microactivated suspension in a bottle of 237 ml. Manufactured in an FDA-Licensed factory and strictly adhered to the cGMP standard – a guarantee of quality and safety. It is an immunomodulator – it optimizes the functioning of the immune system. Promotes the stimulation of recovery processes, increasing resistance to pathogens and stress (physical and psychological). Effectively eliminates atypical cells, which prevents the development of tumor (including cancer) diseases. It has anti-inflammatory and adaptogenic effects, increasing the physical and mental performance of the body, improving blood formation. It has no analogue on the market in terms of the effectiveness and safety of immunocorrection. Even at the lowest dosage can significantly change the treatment landscape. It has anti-inflammatory and adaptogenic effects, increasing the physical and mental performance of the body, improving blood formation. It has no analogue on the market in terms of the effectiveness and safety of immunocorrection. Even at the lowest dosage can significantly change the treatment landscape. It has anti-inflammatory and adaptogenic effects, increasing the physical and mental performance of the body, improving hematopoiesis. It has no analogue on the market in terms of the effectiveness and safety of immunocorrection. Even at the lowest dosage can significantly change the treatment landscape.